OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studies

Maarten Boers; Dorcas E. Beaton; Beverley J. Shea; Lara J. Maxwell; Susan J. Bartlett; Clifton O. Bingham; Philip G. Conaghan; Maria Antonietta D’Agostino; Maria Antonietta D'Agostino; Maarten P. De Wit; Laure Gossec; Lyn March; Lee S. Simon; Jasvinder A. Singh; Vibeke Strand; George A. Wells; Peter Tugwell

doi:10.3899/jrheum.181096

OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studies

Maarten Boers, Dorcas E. Beaton, Beverley J. Shea, Lara J. Maxwell, Susan J. Bartlett, Clifton O. Bingham, Philip G. Conaghan, Maria Antonietta D’Agostino, Maria Antonietta D'Agostino, Maarten P. De Wit, Laure Gossec, Lyn March, Lee S. Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells, Peter Tugwell

Risultato della ricerca: Contributo in rivista › Articolo in rivista

32 Citazioni (Scopus)

Abstract

Objective. The Outcome Measures in Rheumatology (OMERACT) Filter 2.0 framework was developed in 2014 to aid core outcome set development by describing the full universe of “measurable aspects of health conditions” from which core domains can be selected. This paper provides elaborations and updated concepts (OMERACT Filter 2.1). Methods. At OMERACT 2018, we discussed challenges in the framework application caused by unclear or ambiguous wording and terms and incompletely developed concepts. Results. The updated OMERACT Filter 2.1 framework makes benefits and harms explicit, clarifies concepts, and improves naming of various terms. Conclusion. We expect that the Filter 2.1 framework will improve the process of core set development.

Lingua originale	English
pagine (da-a)	1021-1027
Numero di pagine	7
Rivista	THE JOURNAL OF RHEUMATOLOGY
Volume	46
DOI	https://doi.org/10.3899/jrheum.181096
Stato di pubblicazione	Pubblicato - 2019

Keywords

Antirheumatic Agents
Clinical Trials as Topic
Health Status Indicators
Health status indicator
Humans
Measurement model
OMERACT
Outcome Assessment, Health Care
Patient outcome
Rheumatic Diseases
Rheumatology
Theoretical framework

Accesso al documento

10.3899/jrheum.181096

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Boers, M., Beaton, D. E., Shea, B. J., Maxwell, L. J., Bartlett, S. J., Bingham, C. O., Conaghan, P. G., D’Agostino, M. A., D'Agostino, M. A., De Wit, M. P., Gossec, L., March, L., Simon, L. S., Singh, J. A., Strand, V., Wells, G. A., & Tugwell, P. (2019). OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studies. THE JOURNAL OF RHEUMATOLOGY, 46, 1021-1027. https://doi.org/10.3899/jrheum.181096

@article{85c57247765445ae9e990b699e6e3368,

title = "OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studies",

abstract = "Objective. The Outcome Measures in Rheumatology (OMERACT) Filter 2.0 framework was developed in 2014 to aid core outcome set development by describing the full universe of “measurable aspects of health conditions” from which core domains can be selected. This paper provides elaborations and updated concepts (OMERACT Filter 2.1). Methods. At OMERACT 2018, we discussed challenges in the framework application caused by unclear or ambiguous wording and terms and incompletely developed concepts. Results. The updated OMERACT Filter 2.1 framework makes benefits and harms explicit, clarifies concepts, and improves naming of various terms. Conclusion. We expect that the Filter 2.1 framework will improve the process of core set development.",

keywords = "Antirheumatic Agents, Clinical Trials as Topic, Health Status Indicators, Health status indicator, Humans, Measurement model, OMERACT, Outcome Assessment, Health Care, Patient outcome, Rheumatic Diseases, Rheumatology, Theoretical framework, Antirheumatic Agents, Clinical Trials as Topic, Health Status Indicators, Health status indicator, Humans, Measurement model, OMERACT, Outcome Assessment, Health Care, Patient outcome, Rheumatic Diseases, Rheumatology, Theoretical framework",

author = "Maarten Boers and Beaton, {Dorcas E.} and Shea, {Beverley J.} and Maxwell, {Lara J.} and Bartlett, {Susan J.} and Bingham, {Clifton O.} and Conaghan, {Philip G.} and D{\textquoteright}Agostino, {Maria Antonietta} and D'Agostino, {Maria Antonietta} and {De Wit}, {Maarten P.} and Laure Gossec and Lyn March and Simon, {Lee S.} and Singh, {Jasvinder A.} and Vibeke Strand and Wells, {George A.} and Peter Tugwell",

year = "2019",

doi = "10.3899/jrheum.181096",

language = "English",

volume = "46",

pages = "1021--1027",

journal = "THE JOURNAL OF RHEUMATOLOGY",

issn = "0315-162X",

publisher = "Journal of Rheumatology:920 Yonge Street, Suite 115, Toronto Ontario M4W 3C7 Canada:(416)967-5155, EMAIL: [email protected], INTERNET: http://jrheum.com, Fax: (416)967-7556",

}

Boers, M, Beaton, DE, Shea, BJ, Maxwell, LJ, Bartlett, SJ, Bingham, CO, Conaghan, PG, D’Agostino, MA, D'Agostino, MA, De Wit, MP, Gossec, L, March, L, Simon, LS, Singh, JA, Strand, V, Wells, GA & Tugwell, P 2019, 'OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studies', THE JOURNAL OF RHEUMATOLOGY, vol. 46, pagg. 1021-1027. https://doi.org/10.3899/jrheum.181096

TY - JOUR

T1 - OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studies

AU - Boers, Maarten

AU - Beaton, Dorcas E.

AU - Shea, Beverley J.

AU - Maxwell, Lara J.

AU - Bartlett, Susan J.

AU - Bingham, Clifton O.

AU - Conaghan, Philip G.

AU - D’Agostino, Maria Antonietta

AU - D'Agostino, Maria Antonietta

AU - De Wit, Maarten P.

AU - Gossec, Laure

AU - March, Lyn

AU - Simon, Lee S.

AU - Singh, Jasvinder A.

AU - Strand, Vibeke

AU - Wells, George A.

AU - Tugwell, Peter

PY - 2019

Y1 - 2019

N2 - Objective. The Outcome Measures in Rheumatology (OMERACT) Filter 2.0 framework was developed in 2014 to aid core outcome set development by describing the full universe of “measurable aspects of health conditions” from which core domains can be selected. This paper provides elaborations and updated concepts (OMERACT Filter 2.1). Methods. At OMERACT 2018, we discussed challenges in the framework application caused by unclear or ambiguous wording and terms and incompletely developed concepts. Results. The updated OMERACT Filter 2.1 framework makes benefits and harms explicit, clarifies concepts, and improves naming of various terms. Conclusion. We expect that the Filter 2.1 framework will improve the process of core set development.

AB - Objective. The Outcome Measures in Rheumatology (OMERACT) Filter 2.0 framework was developed in 2014 to aid core outcome set development by describing the full universe of “measurable aspects of health conditions” from which core domains can be selected. This paper provides elaborations and updated concepts (OMERACT Filter 2.1). Methods. At OMERACT 2018, we discussed challenges in the framework application caused by unclear or ambiguous wording and terms and incompletely developed concepts. Results. The updated OMERACT Filter 2.1 framework makes benefits and harms explicit, clarifies concepts, and improves naming of various terms. Conclusion. We expect that the Filter 2.1 framework will improve the process of core set development.

KW - Antirheumatic Agents

KW - Clinical Trials as Topic

KW - Health Status Indicators

KW - Health status indicator

KW - Humans

KW - Measurement model

KW - OMERACT

KW - Outcome Assessment, Health Care

KW - Patient outcome

KW - Rheumatic Diseases

KW - Rheumatology

KW - Theoretical framework

KW - Antirheumatic Agents

KW - Clinical Trials as Topic

KW - Health Status Indicators

KW - Health status indicator

KW - Humans

KW - Measurement model

KW - OMERACT

KW - Outcome Assessment, Health Care

KW - Patient outcome

KW - Rheumatic Diseases

KW - Rheumatology

KW - Theoretical framework

UR - http://hdl.handle.net/10807/168506

U2 - 10.3899/jrheum.181096

DO - 10.3899/jrheum.181096

M3 - Article

SN - 0315-162X

VL - 46

SP - 1021

EP - 1027

JO - THE JOURNAL OF RHEUMATOLOGY

JF - THE JOURNAL OF RHEUMATOLOGY

ER -

OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studies

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo